Glenvog 2mg/500mg/0.2mg Tablet
Marketer
Astonea Labs Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glenvog 2mg/500mg/0.2mg Tablet
Diabeticaid 2mg/500mg/0.2mg tablets are classified as anti-diabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to effectively manage blood glucose levels. Diabeticaid 2mg/500mg/0.2mg tablets should be ingested with meals, consistently at the same time daily for optimal therapeutic benefit. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and treat these symptoms; maintaining regular meals and carrying a readily available glucose source (e.g., sugary foods or juice) is essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should consult their doctor before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Glenvog 2mg/500mg/0.2mg Tablet
No text provided. Please provide the text you wish to be rewritten.
Uses of Glenvog 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glenvog 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the Glenvog 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Glenvog 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glenvog 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glenvog 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
How Glenvog 2mg/500mg/0.2mg Tablet works:
Each Glenvog tablet (2mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glenvog 2mg/500mg/0.2mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glenvog 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Glenvog 2mg/500mg/0.2mg Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Glenvog 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be forgone. Patients with severe kidney disease should especially avoid this medication. Medical advice is recommended.
LiverCAUTION
Patients with liver impairment should use Glenvog 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glenvog 2mg/500mg/0.2mg Tablet :
Should you forget a Glenvog 2mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glenvog 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently